#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	15454	16S	1529	1529	100.0	16S.l15.c17.ctg.1	2461	770.7	1	SNP	n	C1184T	0	.	.	1184	1184	C	1617	1617	C	902	C,A,T	900,1,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26140	23S	2890	2890	99.9	23S.l6.c4.ctg.1	3898	833.6	0	.	n	.	0	T695C	SNP	695	695	T	1206	1206	C	964	C,T	959,4	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26140	23S	2890	2890	99.9	23S.l6.c4.ctg.1	3898	833.6	0	.	n	.	0	G1337A	SNP	1337	1337	G	1848	1848	A	1009	A,G,T,C	1004,3,1,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26140	23S	2890	2890	99.9	23S.l6.c4.ctg.1	3898	833.6	0	.	n	.	0	T1971C	SNP	1971	1971	T	2482	2482	C	913	C,A	910,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26140	23S	2890	2890	99.9	23S.l6.c4.ctg.1	3898	833.6	1	SNP	n	A2045G	0	.	.	2045	2045	A	2556	2556	A	875	A,G	874,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26140	23S	2890	2890	99.9	23S.l6.c4.ctg.1	3898	833.6	1	SNP	n	C2597T	0	.	.	2597	2597	C	3108	3108	C	962	C	960	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_O_01412c	folP.WHO_O_01412c	1	1	27	2044	folP	855	855	100.0	folP.l15.c17.ctg.1	2075	122.6	1	SNP	p	R229S	1	.	.	685	687	AGC	1385	1387	AGC	216;218;219	A,C;G;C	214,1;217;218	folP.WHO_O_01412c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4926	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3960	155.0	1	SNP	p	S91F	1	.	.	271	273	TTC	855	857	TTC	188;189;190	T,A;T;C	187,1;189;190	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4926	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3960	155.0	1	SNP	p	D95G	1	.	.	283	285	GGC	867	869	GGC	198;198;197	G;G;C,G	198;198;196,1	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4926	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3960	155.0	1	SNP	p	G95N	0	.	.	283	285	GGC	867	869	GGC	198;198;197	G;G;C,G	198;198;196,1	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_O_01438	mtrR.WHO_O_01438	1	1	27	1962	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1768	137.7	1	SNP	p	G45D	0	.	.	133	135	GGC	773	775	GGC	196;197;193	G;G;C	196;197;193	mtrR.WHO_O_01438:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	1024	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	1510	84.6	0	.	n	.	0	A197.	DEL	197	197	A	807	807	A	211	A	211	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4820	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3412	175.8	1	SNP	p	D86N	0	.	.	256	258	GAC	792	794	GAC	228;227;225	G,T;A;C	227,1;227;225	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4820	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3412	175.8	1	SNP	p	R87I	0	.	.	259	261	CGT	795	797	CGT	226;227;228	C;G;T	226;227;228	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4820	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3412	175.8	1	SNP	p	R87W	0	.	.	259	261	CGT	795	797	CGT	226;227;228	C;G;T	226;227;228	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4820	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3412	175.8	1	SNP	p	S87R	1	.	.	259	261	CGT	795	797	CGT	226;227;228	C;G;T	226;227;228	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4820	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3412	175.8	1	SNP	p	S88P	0	.	.	262	264	TCC	798	800	TCC	233;232;233	T;C;C	233;232;233	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4026	parE	1986	1986	100.0	parE.l15.c4.ctg.1	3253	154.1	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1806	1808	GGC	232;231;231	G,A;G;C,A	231,1;231;230,1	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.5.002	penA.5.002	1	1	27	3890	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2969	163.1	1	SNP	p	A311V	0	.	.	931	933	GCA	1544	1546	GCA	217;221;219	G,C;C,A;A	216,1;220,1;219	penA.5.002:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3890	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2969	163.1	1	SNP	p	I312M	0	.	.	934	936	ATC	1547	1549	ATC	218;221;219	A;T,C;C	218;220,1;219	penA.5.002:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3890	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2969	163.1	1	SNP	p	V316P	0	.	.	946	948	GTG	1559	1561	GTG	226;227;225	G;T;G	226;227;225	penA.5.002:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3890	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2969	163.1	1	SNP	p	V316T	0	.	.	946	948	GTG	1559	1561	GTG	226;227;225	G;T;G	226;227;225	penA.5.002:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3890	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2969	163.1	1	SNP	p	T484S	0	.	.	1450	1452	ACC	2063	2065	ACC	236;238;237	A;C;C	236;238;237	penA.5.002:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3890	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2969	163.1	1	SNP	p	A502V	0	.	.	1504	1506	GCG	2117	2119	GCG	208;209;209	G;C;G,C	208;209;208,1	penA.5.002:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3890	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2969	163.1	1	SNP	p	A502P	0	.	.	1504	1506	GCG	2117	2119	GCG	208;209;209	G;C;G,C	208;209;208,1	penA.5.002:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3890	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2969	163.1	1	SNP	p	G543S	1	.	.	1627	1629	AGC	2240	2242	AGC	220;220;219	A;G;C,G	220;220;218,1	penA.5.002:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3890	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2969	163.1	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2249	2251	GGC	217;215;216	G;G;C,A	217;215;215,1	penA.5.002:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3890	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2969	163.1	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2267	2269	CCG	218;220;218	C,G,A;C;G,C	215,2,1;220;217,1	penA.5.002:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5340	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3623	183.9	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1895	1897	CCG	202;203;199	C;C,T;G	202;202,1;199	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2374	porA	1146	1146	99.91	porA.l15.c17.ctg.1	2310	128.3	0	.	p	.	0	M83fs	FSHIFT	247	247	A	814	814	C	172	C,A	171,1	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	512	298	porB1a	984	226	90.27	porB1a.l15.c17.ctg.1	620	20.2	0	.	p	.	0	V258L	NONSYN	772	774	GTA	14	16	TTA	33;34;36	T;T;A	33;34;36	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	512	298	porB1a	984	226	90.27	porB1a.l15.c17.ctg.1	620	20.2	0	.	p	.	0	Y273H	NONSYN	817	819	TAT	59	61	CAT	62;62;62	C;A;T	62;62;62	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	512	298	porB1a	984	226	90.27	porB1a.l15.c17.ctg.1	620	20.2	0	.	p	.	0	D274S	NONSYN	820	822	GAT	62	64	AGT	62;62;62	A;G,A;T	62;61,1;62	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	512	298	porB1a	984	226	90.27	porB1a.l15.c17.ctg.1	620	20.2	0	.	p	.	0	N277Y	NONSYN	829	831	AAC	71	73	TAC	62;62;62	T;A,G;C	62;61,1;62	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	512	298	porB1a	984	226	90.27	porB1a.l15.c17.ctg.1	620	20.2	0	.	p	.	0	R307A	NONSYN	919	921	AGA	161	163	GCA	2;2;2	G;C;A	2;2;2	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	512	298	porB1a	984	226	90.27	porB1a.l15.c17.ctg.1	620	20.2	0	.	p	.	0	T311A	NONSYN	931	933	ACA	173	175	GCA	3;3;3	G;C;A	3;3;3	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	512	298	porB1a	984	226	90.27	porB1a.l15.c17.ctg.1	620	20.2	0	.	p	.	0	E312D	NONSYN	934	936	GAA	176	178	GAC	3;3;3	G;A;C	3;3;3	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	512	298	porB1a	984	226	90.27	porB1a.l15.c17.ctg.1	620	20.2	0	.	p	.	0	F314I	NONSYN	940	942	TTC	182	184	ATC	4;4;4	A;T;C	4;4;4	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	512	298	porB1a	984	226	90.27	porB1a.l15.c17.ctg.1	620	20.2	0	.	p	.	0	A316S	NONSYN	946	948	GCG	188	190	TCG	6;7;7	T;C;G	6;7;7	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	512	298	porB1a	984	226	90.27	porB1a.l15.c17.ctg.1	620	20.2	0	.	p	.	0	V318A	NONSYN	952	954	GTC	194	196	GCC	7;7;7	G;C;C	7;7;7	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	512	298	porB1a	984	226	90.27	porB1a.l15.c17.ctg.1	620	20.2	0	.	p	.	0	G319S	NONSYN	955	957	GGC	197	199	AGC	7;7;7	A,T;G;C	6,1;7;7	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	512	298	porB1a	984	226	90.27	porB1a.l15.c17.ctg.1	620	20.2	0	.	p	.	0	G320A	NONSYN	958	960	GGT	200	202	GCC	7;7;7	G;C;C	7;7;7	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	512	298	porB1a	984	226	90.27	porB1a.l15.c17.ctg.1	620	20.2	0	.	p	.	0	G322V	NONSYN	964	966	GGT	206	208	GTT	7;7;7	G;T;T	7;7;7	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	512	298	porB1a	984	100	94.0	porB1a.l15.c17.ctg.2	182	48.8	0	.	p	.	0	M18T	NONSYN	52	54	ATG	133	135	ACG	55;51;48	A;C;G	55;51;48	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	512	298	porB1a	984	100	94.0	porB1a.l15.c17.ctg.2	182	48.8	0	.	p	.	0	E32Q	NONSYN	94	96	GAA	175	177	CAA	16;13;11	C;A;A	16;13;11	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3184	porB1b	1047	1047	99.33	porB1b.l6.c4.ctg.1	1934	204.2	0	.	p	.	0	N38E	NONSYN	112	114	AAT	636	638	GAA	253;252;249	G;A,C;A,C	253;251,1;248,1	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3184	porB1b	1047	1047	99.33	porB1b.l6.c4.ctg.1	1934	204.2	0	.	p	.	0	N134D	NONSYN	400	402	AAT	924	926	GAT	258;259;258	G,C;A;T,A	256,1;259;257,1	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3184	porB1b	1047	1047	99.33	porB1b.l6.c4.ctg.1	1934	204.2	0	.	p	.	0	P175S	NONSYN	523	525	CCA	1047	1049	TCA	283;285;284	T;C,T,G;A	283;283,1,1;284	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3184	porB1b	1047	1047	99.33	porB1b.l6.c4.ctg.1	1934	204.2	0	.	p	.	0	A218V	NONSYN	652	654	GCC	1176	1178	GTC	292;292;293	G;TCCCC,TCCC;C	292;283,1;293	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3184	porB1b	1047	1047	99.33	porB1b.l6.c4.ctg.1	1934	204.2	0	.	p	.	0	E328A	NONSYN	982	984	GAA	1506	1508	GCA	279;278;279	G;C;A	279;278;279	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3184	porB1b	1047	1047	99.33	porB1b.l6.c4.ctg.1	1934	204.2	1	SNP	p	G120K	1	.	.	358	360	AAG	882	884	AAG	257;258;258	A;A,C;G,T	257;257,1;257,1	porB1b.WHO_V_02265c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3184	porB1b	1047	1047	99.33	porB1b.l6.c4.ctg.1	1934	204.2	1	SNP	p	D121N	0	.	.	361	363	GAC	885	887	GAC	260;263;264	G,C;A;C	258,1;263;264	porB1b.WHO_V_02265c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3184	porB1b	1047	1047	99.33	porB1b.l6.c4.ctg.1	1934	204.2	1	SNP	p	A121D	1	.	.	361	363	GAC	885	887	GAC	260;263;264	G,C;A;C	258,1;263;264	porB1b.WHO_V_02265c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	9980	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	5376	231.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1440	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1351	132.7	1	SNP	p	V57M	1	.	.	169	171	ATG	699	701	ATG	271;271;267	A;T;G	271;271;267	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
